MARKET

ACOG

ACOG

Alpha Cognition
NASDAQ
5.08
-0.26
-4.87%
Closed 16:10 03/27 EDT
OPEN
5.01
PREV CLOSE
5.34
HIGH
5.36
LOW
4.870
VOLUME
111.42K
TURNOVER
12.23K
52 WEEK HIGH
11.54
52 WEEK LOW
3.750
MARKET CAP
112.06M
P/E (TTM)
-3.7173
1D
5D
1M
3M
1Y
5Y
1D
Alpha Cognition to hold Annual General Meeting
Reuters · 2d ago
Major Investor Quietly Boosts Stake in Alpha Cognition Inc.
TipRanks · 3d ago
Opaleye Management reports acquisition of Alpha Cognition common shares; value rises to $110,000
Reuters · 3d ago
Alpha Cognition Inc. (ACOG) Reports Q4 Loss, Lags Revenue Estimates
NASDAQ · 3d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 3d ago
Alpha Cognition FY2025 operating loss widened to $23 million; revenue rose to $10.2 million
Reuters · 3d ago
Alpha Cognition Q4 EPS $(0.30) Misses $(0.27) Estimate, Sales $2.793M Miss $3.197M Estimate
Benzinga · 3d ago
Alpha Cognition GAAP EPS of -$1.17 misses by $0.06, revenue of $6.79M misses by $3.89M
Seeking Alpha · 3d ago
More
About ACOG
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.

Webull offers Alpha Cognition Inc stock information, including NASDAQ: ACOG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACOG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACOG stock methods without spending real money on the virtual paper trading platform.